Details for: TEVA-PANTOPRAZOLE
Company: TEVA CANADA LIMITED
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02285479 | TEVA-PANTOPRAZOLE | PANTOPRAZOLE (PANTOPRAZOLE SODIUM SESQUIHYDRATE) | 20 MG | TABLET (DELAYED-RELEASE) | ORAL |
| 02285487 | TEVA-PANTOPRAZOLE | PANTOPRAZOLE (PANTOPRAZOLE SODIUM SESQUIHYDRATE) | 40 MG | TABLET (DELAYED-RELEASE) | ORAL |
Summary Reports
Summary Safety Review - Proton Pump Inhibitors - Assessing the Potential Risk of Clostridium difficile Infection
Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]
Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.